PubRank

J C Kappes

Author PubWeight™ 66.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 1993 12.22
2 High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991 7.01
3 Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol 2000 6.71
4 Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J Virol 1991 5.56
5 A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med 1993 2.98
6 The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol 1995 2.25
7 Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J 1997 2.23
8 Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol 1999 2.16
9 Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol 1990 1.86
10 West African HIV-2-related human retrovirus with attenuated cytopathicity. Science 1988 1.86
11 Localization of the Vpx packaging signal within the C terminus of the human immunodeficiency virus type 2 Gag precursor protein. J Virol 1994 1.81
12 Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol 1995 1.77
13 Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 1993 1.48
14 Development of a novel trans-lentiviral vector that affords predictable safety. Mol Ther 2000 1.42
15 The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 1998 1.39
16 Lentiviral vector transduction of hematopoietic stem cells that mediate long-term reconstitution of lethally irradiated mice. Stem Cells 2000 1.17
17 Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir. J Gen Virol 1986 1.06
18 Moloney murine leukemia virus integrase protein augments viral DNA synthesis in infected cells. J Virol 2001 1.03
19 Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein. J Virol 1997 1.01
20 Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins. Virology 1996 0.97
21 Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J Virol 1996 0.96
22 Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide. Arch Virol 1988 0.95
23 Antibody response to herpes simplex virus glycoprotein D: effects of acyclovir and relation to recurrence. J Infect Dis 1987 0.92
24 Polyclonal rabbit antisera that detect the Vpr protein of SIVSM and SIVMAC on immunoblots of purified virions. AIDS Res Hum Retroviruses 1995 0.86
25 Analysis of human immunodeficiency virus type 1 containing HERV-K protease. AIDS Res Hum Retroviruses 2000 0.84
26 Targeting human immunodeficiency virus (HIV) type 2 integrase protein into HIV type 1. J Virol 1999 0.84
27 Enhanced in vitro reactivation of herpes simplex virus type 2 from latently infected guinea-pig neural tissues by 5-azacytidine. J Gen Virol 1988 0.82
28 Viral dynamics in primary HIV-1 infection. Lancet 1993 0.81
29 Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases). J Clin Microbiol 1994 0.79
30 Antibody to herpes simplex virus (HSV) ICP-35 proteins after HSV challenge of animals immunized with HSV subunit vaccines. J Infect Dis 1988 0.78
31 Analysis of lenti- and trans-lentiviral vector genetic recombination. Dev Biol (Basel) 2001 0.77